Indivior Pharmaceuticals, Inc. INDV Business Segments — Operating Expenses

Similar metrics at other companies

GWREReportable Segment — Operating Expenses

$206.01M+15.6%

BTGOReportable Segment — Operating Expenses

$3.79B+114%

PCVXReportable Segment — Operating Expenses

$345.85M+91.3%

FPSReportable Segment — Operating Expenses

$91.86M+101%

ANDGReportable Segment — Operating Expenses

$216.67M+39.4%

SLMReportable Segment — Operating Expenses

$170.36M+10.9%

FAQ

What is Indivior Pharmaceuticals, Inc.'s business segments — operating expenses?

Indivior Pharmaceuticals, Inc. (INDV) reported business segments — operating expenses of $139M in Q1 2026.

How has Indivior Pharmaceuticals, Inc.'s business segments — operating expenses changed year-over-year?

Indivior Pharmaceuticals, Inc.'s business segments — operating expenses decreased by 10.9% year-over-year, from $156M to $139M.

What is the long-term trend for Indivior Pharmaceuticals, Inc.'s business segments — operating expenses?

Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc.'s business segments — operating expenses has grown at a -4.1% compound annual growth rate (CAGR), from $831M to $732M.

What does business segments — operating expenses mean?

The aggregate of all operating costs, including selling, general, administrative, and research expenses incurred by the segment. This metric provides a comprehensive view of the operational burden required to sustain the segment's business activities.